Intended for healthcare professionals


FDA advisory panel calls for suicide warnings over new antidepressantss

BMJ 2004; 328 doi: (Published 05 February 2004) Cite this as: BMJ 2004;328:303
  1. Ray Moynihan
  1. Washington

In a surprise move on 2 February, a panel of scientific advisers of the US Food and Drug Administration urged the agency to warn that new anti-depressants may increase the risk of suicidal thinking or behaviour among children and teenagers.

During a 10 hour hearing, experts weighed the official presentations of uncertain scientific data against powerful emotional testimony from dozens of families whose children have killed themselves or others after …

View Full Text

Log in

Log in through your institution


* For online subscription